Dysregulation of mTOR signaling in neuropsychiatric disorders: therapeutic implications

Neuropsychopharmacology. 2012 Jan;37(1):305-6. doi: 10.1038/npp.2011.210.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autistic Disorder / drug therapy*
  • Autistic Disorder / metabolism
  • Fragile X Syndrome / drug therapy*
  • Fragile X Syndrome / metabolism
  • Humans
  • Mice
  • Psychopharmacology / methods
  • Signal Transduction / drug effects*
  • Signal Transduction / physiology
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • TOR Serine-Threonine Kinases / physiology*

Substances

  • MTOR protein, human
  • mTOR protein, mouse
  • TOR Serine-Threonine Kinases